Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma
Clinical trial NCT07131345 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07131345
- Sponsor
- National Cancer Center, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-10-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.